Protagonist Therapeutics Inc
NASDAQ:PTGX

Watchlist Manager
Protagonist Therapeutics Inc Logo
Protagonist Therapeutics Inc
NASDAQ:PTGX
Watchlist
Price: 55.68 USD 2.39% Market Closed
Market Cap: 3.5B USD

Intrinsic Value

The intrinsic value of one PTGX stock under the Base Case scenario is hidden USD. Compared to the current market price of 55.68 USD, Protagonist Therapeutics Inc is hidden .

The Intrinsic Value is calculated as the average of DCF and Relative values:

PTGX Intrinsic Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation History
Protagonist Therapeutics Inc

Intrinsic Value History
Dive into the past to invest in the future

PTGX looks overvalued. Yet it might still be cheap by its own standards. Some stocks live permanently above intrinsic value; Historical Valuation reveals whether PTGX usually does or if today's premium is unusual.

Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Show Historical Valuation

Fundamental Analysis

Company Overview
Loading...
Business Segments
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about PTGX?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about Protagonist Therapeutics Inc
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Protagonist Therapeutics Inc

Current Assets 605.9m
Cash & Short-Term Investments 574.4m
Receivables 27.1m
Other Current Assets 4.4m
Non-Current Assets 136.3m
Long-Term Investments 123.5m
PP&E 12.5m
Other Non-Current Assets 225k
Efficiency

Free Cash Flow Analysis
Protagonist Therapeutics Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Protagonist Therapeutics Inc

Revenue
207.8m USD
Operating Expenses
-180.6m USD
Operating Income
27.2m USD
Other Expenses
29m USD
Net Income
56.2m USD
Fundamental Scores

PTGX Profitability Score
Profitability Due Diligence

Protagonist Therapeutics Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.

Exceptional 3-Years Revenue Growth
ROE is Increasing
ROIC is Increasing
Positive ROIC
hidden
Profitability
Score

Protagonist Therapeutics Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.

PTGX Solvency Score
Solvency Due Diligence

Protagonist Therapeutics Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
Low D/E
hidden
Solvency
Score

Protagonist Therapeutics Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

PTGX Price Targets Summary
Protagonist Therapeutics Inc

Wall Street analysts forecast PTGX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for PTGX is 70.38 USD with a low forecast of 41.41 USD and a high forecast of 86.1 USD.

Lowest
Price Target
41.41 USD
26% Downside
Average
Price Target
70.38 USD
26% Upside
Highest
Price Target
86.1 USD
55% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Protagonist Therapeutics Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for PTGX is hidden .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
HIDDEN
Show
Dividend Yield
No dividends
Buyback Yield
HIDDEN
Debt Paydown Yield
HIDDEN

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

PTGX Insider Trading
Buy and sell transactions by insiders

PTGX News

Other Videos
What is the Intrinsic Value of one PTGX stock?

The intrinsic value of one PTGX stock under the Base Case scenario is hidden USD.

Is PTGX stock undervalued or overvalued?

Compared to the current market price of 55.68 USD, Protagonist Therapeutics Inc is hidden .

Back to Top